David S. Rosenblatt, MD
Dr. Rosenblatt directs one of only two referral laboratories in the world for patients suspected of having an inborn error of vitamin B12 or folate metabolism. As a result of the study of cells from these patients, he has been able to define novel steps in intracellular vitamin B12 metabolism and to identify three complementation groups (cblE, cblF, cblG). Since 2000, he and his collaborators have identified the genes for 5 disorders: cblA (MMAA), cblB (MMAB), cblC (MMACHC), cblD (MMADHC), and cblF (LMBRD1). This has led to a more complete understanding of vitamin metabolism and better approaches to diagnosis and carrier detection for these disorders.


